Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidance
Introduction Patients with muscle invasive bladder cancer (MIBC) who are unfit and unsuitable for standard radical treatment with cystectomy or daily radiotherapy present a large unmet clinical need. Untreated, they suffer high cancer specific mortality and risk significant disease-related local sym...
Main Authors: | Rebecca Lewis, Emma Hall, Shaista Hafeez, Emma Patel, Amanda Webster, Karole Warren-Oseni, Vibeke Hansen, Helen McNair, Elizabeth Miles, Robert Huddart |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-05-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/5/e037134.full |
Similar Items
-
Recognising the challenges of implementing multi-centre adaptive plan of the day radiotherapy
by: Amanda Webster, et al.
Published: (2022-03-01) -
Quality assuring “Plan of the day” selection in a multicentre adaptive bladder trial: Implementation of a pre-accrual IGRT guidance and assessment module
by: Emma Patel, et al.
Published: (2019-11-01) -
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac
by: A. Mitchell, et al.
Published: (2022-07-01) -
A multicentre NCRI phase II study of hypofractionated conformal radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer
by: Choudhury, A, et al.
Published: (2010) -
HYPOFRACTIONATED RADIOTHERAPY IN GLIOBLASTOMA MULTIFORME
by: Sadaf Usman, et al.
Published: (2015-11-01)